Technologies and Global Markets" was valued at $27.6 billion in 2024 and is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of ...

Researchers in the Global Neurodegeneration Proteomics Consortium (GNPC) examined proteins in the body that can be used to track neurological diseases.

Detailed price information for Nautilus Biotechnology Inc (NAUT-Q) from The Globe and Mail including charting and trades.

In recent years, the fusion of deep tech with red and gold biotech has ushered in a new era in medicine, one defined by ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

The AI model, GeneAgent, reduces hallucinations for gene-set analysis by autonomously interacting with biology databases to verify output.

Neurogene Inc.’s disclosure June 30 of its registrational trial design in Rett syndrome (RS) added spice to the space, where Taysha Gene Therapies Inc. is another closely watched player. The New ...

Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive ...

The global chromatography instruments market is set to witness a growth rate of 5% in the next 5 years. Growing application in pharmaceutical and biotech R&D; growing food safety concerns, ...

Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual ...

Beyond healthcare OneMedNet's proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities, rigorously testing production system upgrades, ...